stockportfolio.pro
Quest Diagnostics Incorporated Free Cash Flow 2007–2025
Quest Diagnostics Incorporated (DGX) annual free cash flow by fiscal year, computed from SEC filings. Compound growth +3.7%/yr over 18 years.
| Fiscal year | Free Cash Flow | Change (YoY) |
|---|---|---|
| FY 2025 | $1.36B | +49.5% |
| FY 2024 | $909.00M | +5.2% |
| FY 2023 | $864.00M | -34.2% |
| FY 2022 | $1.31B | -28.2% |
| FY 2021 | $1.83B | +15.3% |
| FY 2020 | $1.59B | +88.3% |
| FY 2019 | $843.00M | +3.2% |
| FY 2018 | $817.00M | -11.5% |
| FY 2017 | $923.00M | +12.2% |
| FY 2016 | $823.00M | +47.5% |
| FY 2015 | $558.00M | -12.3% |
| FY 2014 | $636.00M | +51.1% |
| FY 2013 | $421.00M | -58.1% |
| FY 2012 | $1.00B | +36.9% |
| FY 2011 | $734.00M | -19.6% |
| FY 2010 | $912.65M | +9.9% |
| FY 2009 | $830.49M | -2.3% |
| FY 2008 | $850.37M | +20.1% |
| FY 2007 | $707.82M | — |
Source: Quest Diagnostics Incorporated SEC filings — cash flow statement (10-K). Refreshed nightly.
See the full picture for Quest Diagnostics Incorporated
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeQuest Diagnostics Incorporated — frequently asked questions
What is Quest Diagnostics Incorporated's free cash flow?
Quest Diagnostics Incorporated (DGX) reported free cash flow of $1.36B for fiscal year 2025, per its SEC filings.
How has Quest Diagnostics Incorporated's free cash flow changed over time?
Between fiscal 2007 and 2025, DGX's free cash flow grew at roughly 3.7% per year (compound annual rate), from $707.82M to $1.36B.
Where does this data come from?
Figures are computed from Quest Diagnostics Incorporated's official SEC filings (cash flow statement (10-K)), refreshed nightly. Not investment advice.